OA02.05 CK-101 (RX518), a Third Generation Mutant-Selective...

Journal of Thoracic Oncology 2018 / 10 Vol. 13; Iss. 10

OA02.05 CK-101 (RX518), a Third Generation Mutant-Selective Inhibitor of EGFR in NSCLC: Results of an Ongoing Phase I/II Trial

Johnson, M., Karlix, J., Burris, H., Jones, S., Harris, D., O'Byrne, K., Sriuranpong, V., Charoentum, C., Prasongsook, N., Jitpewngam, W., Wirasorn, K., Wang, J., Waqar, S., Oliviero, J., Gorelik, L.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.242
Date:
October, 2018
File:
PDF, 124 KB
2018
Conversion to is in progress
Conversion to is failed